North China Pharmaceutical Company.Ltd (SHA:600812)

China · Delayed Price · Currency is CNY

4.680

-0.020 (-0.43%)

Oct 28, 2026, 1:15 PM CST

Market Cap	8.03B -23.0%
Revenue (ttm)	7.77B -17.4%
Net Income	89.44M -30.9%
EPS	0.05 -30.8%
Shares Out	1.72B
PE Ratio	88.92
Forward PE	n/a
Dividend	0.04 (0.75%)
Ex-Dividend Date	Jun 11, 2026

Volume	50,887,444
Open	4.660
Previous Close	4.700
Day's Range	4.560 - 4.740
52-Week Range	4.110 - 6.900
Beta	0.20
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 28, 2026

About SHA:600812

North China Pharmaceutical Company.Ltd engages in the research and development, production, and sale of pharmaceutical products in China and internationally. The company primarily offers anti-infective, biotechnology, and cardiovascular cerebrovascular drugs; and immunomodulators, vitamins, and health products. It also provides chemical, biological, agricultural, and biopharmaceuticals and veterinary drugs. It serves pharmaceutical distributors, agents, hospitals, chain pharmacies, and end-user clinics. North China Pharmaceutical Company.Ltd wa... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 1992

Employees 9,972

Stock Exchange Shanghai Stock Exchange

Ticker Symbol 600812

Full Company Profile

Financial Performance

In 2025, SHA:600812's revenue was 9.24 billion, a decrease of -6.36% compared to the previous year's 9.87 billion. Earnings were 183.06 million, an increase of 44.15%.

Financial Statements